Advanced Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.90 M
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth 61.91%
- Profit Growth 1277.19%
- Ebitda 238.22%
- Net Worth 15.87%
- Total Assets 17.24%
About Advanced Lifesciences
Advanced Lifesciences Private Limited (ALPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 August 2006 and has a history of 18 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.90 M.
The company currently has active open charges totaling ₹1.00 Cr.
Naresh Aggarwal, Rakesh Aggarwal, and Kamal Agarwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85121DL2006PTC152691
- Company No.
152691
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Advanced Lifesciences Private Limited offer?
Advanced Lifesciences Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Medical Tubes, Scalpels, Needles & Scissors, Surgical Needles, Surgical & ICU Equipments, Patient Monitoring System, Medical Equipment & Accessories, Forceps & Graspers, Cautery Machine, Catheter.
Who are the key members and board of directors at Advanced Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Aggarwal  | Director | 29-Aug-2006 | Current |
| Rakesh Aggarwal | Director | 29-Aug-2006 | Current |
| Kamal Agarwal | Director | 29-Aug-2006 | Current |
Financial Performance of Advanced Lifesciences.
Advanced Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.91% increase. The company also saw a substantial improvement in profitability, with a 1277.19% increase in profit. The company's net worth Soared by an impressive increase of 15.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Lifesciences?
In 2023, Advanced Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Golden Builders Pvt LtdNaresh Aggarwal is a mutual person
- Vidyut Engineering And Technologies Private Limited
Naresh Aggarwal and Rakesh Aggarwal are mutual person
- Shakuntlam Infotech Private Limited
Rakesh Aggarwal is a mutual person
- Los Angeles Food Processing Limited
Kamal Agarwal is a mutual person
Charges (Loans)
₹1.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 May 2022 | Hdfc Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Advanced Lifesciences?
Advanced Lifesciences has a workforce of 29 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
